Germline mutations in BRCA1 and BRCA2 genes not only increase the risk of breast and ovarian cancer, but also contribute to the susceptibility of pancreatic and prostate cancer (Breast Cancer Linkage Consortium, 1999; Thompson et al., 2002). This evidence concerns the gene BRCA2 and prostate carcinoma.